-

MedMen Announces Earnings Date Change: Fourth Quarter and Full Year Fiscal 2020 Earnings Call Scheduled for October 15, 2020

LOS ANGELES--(BUSINESS WIRE)--MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF), a leading cannabis retailer with operations across the U.S., today announced that it has changed the previously announced release date of its financial results for the fourth quarter and full year fiscal 2020 ended June 27, 2020. The Company will now release its financial results after market close on Thursday, October 15, 2020.

Following the release of these financial results, at 5:00 PM Eastern that same day, MedMen will host a conference call and audio webcast with Interim Chief Executive Officer, Tom Lynch, Chief Financial Officer, Zeeshan Hyder, and Interim Chief Operating Officer, Tim Bossidy, to discuss the results in further detail.

Webcast Information:

A live audio webcast of the call will be available on the Events and Presentations section of MedMen’s website at: https://investors.medmen.com/events-and-presentations/default.aspx and will be archived for replay.

Calling Information:

Toll Free Dial-In Number: (844) 559-7829
International Dial-In Number: (647) 689-5387
Conference ID: 7573367

ABOUT MEDMEN:

MedMen is a cannabis retailer with flagship locations in Los Angeles, Las Vegas, Chicago, and New York. MedMen offers a robust selection of high-quality products, including MedMen-owned brands [statemade], LuxLyte, and MedMen Red through its premium retail stores, proprietary delivery service, as well as curbside and in-store pick up. MedMen Buds, an industry-first loyalty program, provides exclusive access to promotions, product drops and content. MedMen believes that a world where cannabis is legal and regulated is safer, healthier and happier. Learn more about MedMen and The MedMen Foundation at www.medmen.com

SOURCE: MedMen Enterprises

Contacts

MEDIA CONTACTS:
Esther Song
MedMen
Senior Vice President, Marketing & Communications
Email: communications@medmen.com

INVESTOR RELATIONS CONTACT:
Zeeshan Hyder
MedMen
Chief Financial Officer
Email: investors@medmen.com

MedMen Enterprises Inc.

CNSX:MMEN

Release Summary
Q4 / 2020 Earnings Date Change
Release Versions

Contacts

MEDIA CONTACTS:
Esther Song
MedMen
Senior Vice President, Marketing & Communications
Email: communications@medmen.com

INVESTOR RELATIONS CONTACT:
Zeeshan Hyder
MedMen
Chief Financial Officer
Email: investors@medmen.com

More News From MedMen Enterprises Inc.

MedMen Announces Management and Board Changes

BOCA RATON, Fla.--(BUSINESS WIRE)--MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF), a premier cannabis company, today announced that Ellen Deutsch Harrison has stepped down as the Chief Executive Officer and a Board member effective January 19, 2024 and the Board has appointed Richard Ormond as Chief Restructuring Officer. Furthermore, Michael Serruya, Executive Chairman of the Board, who has served on the Board since August 2021, has stepped down from the Board e...

MedMen Exits Arizona Market, Completing Sale of Local Operations to MINT Cannabis

BOCA RATON, Fla.--(BUSINESS WIRE)--MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF), a premier cannabis company with operations across the United States, today announced that the Company has completed the previously announced sale of its non-core business operations in Arizona to an affiliate of Mint Cannabis (“MINT Cannabis”). The pending sale of the Company’s assets in Nevada to MINT Cannabis awaits regulatory approval for completion. “We are pleased to announce...

MedMen Provides Annual Filing Status Report

BOCA RATON, Fla.--(BUSINESS WIRE)--MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF), a premier cannabis company with operations across the United States, is providing this bi-weekly default status report in accordance with National Policy 12-203 – Management Cease Trade Orders ("NP 12-203"). On November 2, 2023, the Company announced that it had been granted a management cease trade order against the Company’s CEO and CFO (“MCTO”) by its principal regulator, the Br...
Back to Newsroom